Atreca, Inc.

Atreca, Inc.verified

BCEL

Price:

$0.09

Market Cap:

$3.57M

Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria...[Read more]

Industry

Biotechnology

IPO Date

2019-06-20

Stock Exchange

NASDAQ

Ticker

BCEL

The PE Ratio as of July 2024 (TTM) for Atreca, Inc. (BCEL) is -0.04

According to Atreca, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -89.60% compared to the average of -0.38 of the last 4 quarters.

Atreca, Inc. (BCEL) Historical PE Ratio (quarterly & annually)

How has BCEL PE Ratio performed in the past?

The mean historical PE Ratio of Atreca, Inc. over the last ten years is -2.33. The current -0.04 PE Ratio has changed 71.96% with respect to the historical average. Over the past ten years (40 quarters), BCEL's PE Ratio was at its highest in in the September 2023 quarter at -0.07. The PE Ratio was at its lowest in in the March 2019 quarter at -8.90.

Quarterly (TTM)
Annual

Average

-2.33

Median

-1.49

Minimum

-5.97

Maximum

-0.34

Atreca, Inc. (BCEL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Atreca, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 136.34%

Maximum Annual PE Ratio = -0.34

Minimum Annual Increase = -82.81%

Minimum Annual PE Ratio = -5.97

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.34-66.73%
2021-1.03-82.81%
2020-5.9764.52%
2019-3.63136.34%
2018-1.545.84%

Atreca, Inc. (BCEL) Average PE Ratio

How has BCEL PE Ratio performed in the past?

The current PE Ratio of Atreca, Inc. (BCEL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.45

5-year avg

-2.50

10-year avg

-2.33

Atreca, Inc. (BCEL) PE Ratio vs. Peers

How is BCEL’s PE Ratio compared to its peers?

Atreca, Inc.’s PE Ratio is greater than Passage Bio, Inc. (-0.59), less than Homology Medicines, Inc. (-0.01), greater than Stoke Therapeutics, Inc. (-5.97), greater than TCR2 Therapeutics Inc. (-0.44), greater than Revolution Medicines, Inc. (-15.97), greater than Black Diamond Therapeutics, Inc. (-3.84), greater than Harpoon Therapeutics, Inc. (-2.94), greater than Alector, Inc. (-4.52),

Build a custom stock screener for Atreca, Inc. (BCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atreca, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atreca, Inc. (BCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atreca, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Atreca, Inc.'s PE Ratio?

How is the PE Ratio calculated for Atreca, Inc. (BCEL)?

What is the highest PE Ratio for Atreca, Inc. (BCEL)?

What is the 3-year average PE Ratio for Atreca, Inc. (BCEL)?

What is the 5-year average PE Ratio for Atreca, Inc. (BCEL)?

How does the current PE Ratio for Atreca, Inc. (BCEL) compare to its historical average?